What Global Sample Buyers Should Send for China Healthcare Feasibility (and What You Get Back in 1 Business Day)

When a healthcare RFQ lands as "n=200 physicians in China, ASAP," both sides lose time. Buyers wait. Suppliers guess. Feasibility turns into a week of clarification emails.

At Youli Global Limited, we treat feasibility as a product: clear inputs in, a structured view out typically within one business day.

This article is a practical briefing checklist for global sample buyers, fieldwork agencies, and healthcare research teams sourcing China (and China-led multi-country) healthcare respondents.

Why healthcare feasibility is different

Consumer studies often tolerate broad demographics. Healthcare does not.

• HCP work needs specialty, setting, seniority, and sometimes license-era verification logic.
• Patient / caregiver work needs condition definition, treatment experience, and ethics-aware scripting.
• China delivery adds PIPL-aligned process design when personal information is involved especially for cross-border projects.

Public snapshot (site-aligned): Youli covers 50+ countries and regions, 8M+ consumer samples, and 500K+ healthcare professionals and patients combined. Physician-only or specialty-only counts are scoped per RFQ, not as a separate vanity headline.

The minimum brief that unlocks a 1-business-day reply

Send these fields (bullet form is fine):

1. Countries / waves — China only, or China + which markets
2. Audience type — HCP, patient, caregiver, or mixed
3. Definition — specialty / indication / inclusion–exclusion
4. Target N and quotas — soft vs hard quotas
5. LOI / IR assumptions — even rough ranges help
6. Method — CAWI, CATI, IDI, diary, etc.
7. Timing — field start window and hard deadline
8. Exclusions — competing studies, institution rules, language
9. Data destination — who receives identifiable vs coded data (if relevant)

Missing three of these usually means we must ask before quoting which is why "ASAP" RFQs slow down.

What you get back in one business day

When the brief is usable, our feasibility grid typically covers:

• Achievable N (central estimate + risk band)
• Expected field window after soft launch
• Key risks (incidence, specialty depth, seasonality, verification)
• Alternatives (wave design, adjacent specialty, staged quotas)
• Next step — soft hold, pilot, or full quote path

This is not a glossy brochure. It is a decision tool so you can choose whether to proceed.

HCP vs patient — don't mix the clocks

HCP

• Bottleneck: Specialty depth, availability, verification
• Briefing tip: Name specialty + setting + years
• Timeline driver: Quota complexity more than raw N

Patient / caregiver

• Bottleneck: Condition definition, treatment experience
• Briefing tip: Name diagnosis / treatment journey clearly
• Timeline driver: Screener length + incidence

If your study needs both, say so up front. Mixed designs are common — but they are two feasibility problems, not one.

Language that helps (and language that doesn't)

Use

• "PIPL-aligned project setup"
• "Specialty-level feasibility on RFQ"
• "500K+ healthcare professionals and patients combined" (when citing public coverage)

Avoid

• "PIPL-certified" (unless you have a verified seal to show — we don't use this claim)
• Overspecified N with zero audience definition
• Assuming China Tier-1 hospital access is the default path for every HCP study

How to send an RFQ to Youli

Email RFQ@youli.tech
Subject tip: Feasibility — [therapy/audience] — [countries] — [N]

Attach a screener if you have one. If not, the nine fields above are enough to start.

Youli Global Limited — global sample partner for market research buyers. Healthcare is a 2026 priority: China strength, multi-country options, and feasibility built for decision speed.